The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Pulsatile energy consumption as a surrogate marker for vascular afterload improves with time post transcatheter aortic valve replacement in patients with aortic stenosis | Hypertension Research
Surrogate Markers of Chronic Allograft Nephropathy in Man - ppt download
Surrogate Endpoints and Biomarkers | Basicmedical Key
Surrogate Endpoints | Evidera
Diagnostics | Free Full-Text | Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review
Surrogate Endpoint | Definitive Healthcare
Example 1: Continuous Surrogate Marker • OptimalSurrogate
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework | Nature Reviews Drug Discovery
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
FDA Facts: Biomarkers and Surrogate Endpoints | FDA
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
Optimized sensitive and inexpensive method to measure D-lactate as a surrogate marker of methylglyoxal fluxes in metabolically relevant contexts - ScienceDirect
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
JCM | Free Full-Text | Corneal Hysteresis, Intraocular Pressure, and Progression of Glaucoma: Time for a “Hyst-Oric” Change in Clinical Practice?
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age | GeroScience
flowCAST-Basophils-Surrogate-Marker - Buhlmann Diagnostics Corp
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies - ScienceDirect
